We are thrilled to announce that MUB Medical has received financing from Innovation Norway to conduct pre-clinical trials for Sutrips. This marks the third time that Innovation Norway has supported us financially, and we are incredibly grateful for their ongoing trust and belief in our vision.
With the backing of Innovation Norway, we are now focused on preparing for Sutrips’ global market introduction. We will actively engage with key industry players to explore potential collaborations for the successful launch of Sutrips.
It’s an exhilarating time for us, and we invite you to follow us on LinkedIn for more exciting updates. Stay tuned as we share the remarkable results of our proof of concept, which we recently completed.
Thank you for your unwavering support and enthusiasm as we work towards revolutionizing wound care with Sutrips! A simple Scandinavian solution for a complex global problem.